Shenma intends to increase its capital in Adian by 214 million yuan
Time of Update: 2022-12-29
In order to enhance the capital strength of Adian, meet the loan requirements of China Development Bank, and ensure the construction capital needs of the adiponitrile project, Shenma intends to increase the capital of Adian by 214 million yuan in cash.
Kansai Electric Power Company uses natural gas to retrofit thermal power stations
Time of Update: 2022-11-22
On August 18, 2016, the renovation project of Unit 3 of the Aisoi Power Station was completed, and the normal use of natural gas for power generation began.
This time chicken feathers are not used as arrows, Singapore will grind chicken feathers into degradable plastic
Time of Update: 2022-08-17
After adding polyester fibers, they can be made into various plastic products, such as The chassis for the chicken and eggs, It is understood that the researchers of the NTU Food Science and Technology Program used chicken feathers, cleaned and disinfected, and then ground them into powdered keratins.
More than 30 pharmaceutical companies announced their performance reports, and more than half of the companies reported good news
Time of Update: 2022-05-01
In terms of net profit, 28 pharmaceutical companies have a net profit of over 100 million yuan.
In addition, Wantai Bio, Rejing Bio and other net profits exceeded 2 billion yuan .
The company's net profit in 2021 will be -414 million yuan, a year-on-year increase of 95.
Announcement of R&D expenses of 71 pharmaceutical companies: Yiling, Baiyunshan, China Resources Sanjiu
Time of Update: 2022-01-26
Image source: WeChat public account "Pharmaceutical Aspects"Relevant people in the industry believe that according to the current development trend of new traditional Chinese medicines, the market size is expected to exceed one trillion yuan in 2022, and will reach 1.
This multinational pharmaceutical company joins the layoff team, or will lay off more than 1,000 people
Time of Update: 2021-12-25
Recently, it was reported that Bojian plans to lay off more than 1,000 employees due to poor product performance and use it to save up to 750 million U.
Buchang Pharmaceutical's two injections will be withdrawn from the Heilongjiang Provincial Medical Insurance List at the end of the year
Time of Update: 2021-09-05
On the evening of August 16, Buchang Pharmaceutical issued an announcement stating that the drug compound brain peptide ganglioside injection of the holding subsidiary Jilin Tiancheng Pharmaceutical and the drug Guhong injection of the wholly-owned subsidiary Tonghua Guhong Pharmaceutical will be held in December 2021.
Domestic Infliximab is on the market, the autoimmune field is intensified
Time of Update: 2021-08-15
Leike domestic sample hospital sales (ten thousand yuan)Data source: Wind Medical LibraryWith the approval of domestic infliximab, Leike is facing increasingly fierce competition in the domestic market .
Yan Yanna, Deputy General Manager of First Pharmaceutical, resigns
Time of Update: 2021-08-05
("First Pharmaceutical") issued an announcement stating that the board of directors had recently received a written resignation report from the company's deputy general manager Yan Yanna .
Yan Yanna requested to resign from the position of deputy general manager of the company due to personal reasons .
National Medical Insurance Administration: "Zero Tolerance" for Medical Insurance Fraud
Time of Update: 2021-06-17
Medical Network, June 7th, a reporter learned from the China National Medical Insurance Administration on the 6th that the bureau will soon inform the National Medical Insurance System of Anhui Province’s investigation of fraudulent insurance cases in Taihe County, and require medical insurance departments at all levels to deal with medical insurance fraud fraud.
Hundreds of billions of dollars in the API market, who is the main floating
Time of Update: 2020-11-13
industry believes that through the "raw materials and preparations" integrated development model, can also be to a large extent on the volume of procurement brought about by the impact of drug price reduction, and the value of this model has been further recognized by the market.
Shandong belt volume procurement of 40 varieties list published in the selection rules are complex
Time of Update: 2020-11-02
. Fengqiu September 16, the industry out of Shandong Province Health Insurance Bureau "on the organization to fill in part of the drug procurement plan notice", in accordance with the principle of large clinical use, high procurement amount, adequate competition, clinical and pharmaceutical experts selected to determine 40 centralized belt procurement of drug varieties.
Fosun Pharma's new coronavirus mRNA vaccine phase I clinical trial approved
Time of Update: 2020-07-31
the vaccine is a biological product for prevention and is intended to be used mainly for the prevention of new coronavirus pneumonia in people aged 18 and over.
Health Care Bureau: Hospitals will pay back next month
Time of Update: 2020-07-24
July 2, Fujian Provincial Medical Insurance Bureau issued the "Fujian Provincial Medical Security Bureau on the province's fixed-point public medical institutions to do a good job of the province's
Sustained high-quality growth, aticipation of the annual report of Ayer Ophthalmology
Time of Update: 2020-06-03
Pharmaceuticals.com, January 19 (Xinhua) -- Yesterday, Eyre Eye released its 2016 annual results, with net profit attributable to shareholders of listed companies at 53,505.5 million yuan - 57,785.9